SILO Silo Pharma, Inc. Gross Profitability

SILO (silopharma.com) - company brandmark

Silo Pharma, Inc. (SILO) operates in the mental health niche, facing revenue deficits and a reliance on investment. On GURU.Markets, the actual gross margin is available as a trend, and this metric has reached the level of -1356.70. Growth potential is driven by academic partnerships to develop dementia therapies and professional management focused on clinical trial transparency and regulatory standards.

Return on Gross Profit: silopharma.com (SILO) for 04/28/2023 - 11/20/2026

Financial and market metric breakdowns for Silo Pharma (SILO)

- current quotes and average value forecast:
Fundamental valuation:Silo Pharma, Inc.
Product sample of silopharma.com

High R&D expenditures and patent protection for Silo Pharma, Inc. (SILO) subnasal products drive gross margin volatility. This indicator captures the portion of revenue remaining after covering direct production costs, reflecting the business's operational efficiency. The percentage difference between total revenue and the cost of goods sold allows for an assessment of the fundamental stability of this high-risk biopharmaceutical asset.